SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-003788
Filing Date
2017-03-09
Accepted
2017-03-09 08:15:26
Documents
3
Period of Report
2017-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K FYE 2016 atra-8k_20170309.htm 8-K 38685
2 EX-99.1 atra-ex991_6.htm EX-99.1 150694
3 GRAPHIC g2017030912240326730854.jpg GRAPHIC 58005
  Complete submission text file 0001564590-17-003788.txt   270605
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36548 | Film No.: 17676849
SIC: 2836 Biological Products, (No Diagnostic Substances)